Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loris De Cecco

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Oncoimmunology|June 22, 2012
Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?Michele Sommariva, Loris De Cecco, Elda Tagliabue, et al.
Expert Review of Molecular Diagnostics|April 6, 2011
miRNA control of apoptotic programs: focus on ovarian cancerDelia Mezzanzanica, Silvana Canevari, Loris De Cecco, et al.
Cancers|April 3, 2021
Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent DatasetsLoris De Cecco, Marina Bagnoli, Paolo Chiodini, et al.
The International Journal of Biochemistry & Cell Biology|December 29, 2009
Role of microRNAs in ovarian cancer pathogenesis and potential clinical implicationsDelia Mezzanzanica, Marina Bagnoli, Loris De Cecco, et al.
Current Treatment Options in Oncology|May 6, 2017
Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?Luca Tonella, Marco Giannoccaro, Salvatore Alfieri, et al.
Critical Reviews in Oncogenesis|April 26, 2013
Measuring microRNA expression levels in oncology: from samples to data analysisLoris De Cecco, Matteo Dugo, Silvana Canevari, et al.
International Journal of Oncology|September 25, 2008
Clusterin: a potential target for improving response to antiestrogensSara Toffanin, Maria Grazia Daidone, Patrizia Miodini, et al.
Clinical Therapeutics|October 22, 2019
Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck CancerCarla Rognoni, Silvana Quaglini, Jan Baptist Vermorken, et al.
The Journal of Molecular Diagnostics : JMD|December 25, 2012
MicroRNA detection in plasma samples: how to treat heparinized plasmaPaola Tiberio, Loris De Cecco, Maurizio Callari, et al.
Genes|September 8, 2019
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot StudyMatteo Dugo, Andrea Devecchi, Loris De Cecco, et al.
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Oncoimmunology|June 22, 2012
Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?Michele Sommariva, Loris De Cecco, Elda Tagliabue, et al.
Expert Review of Molecular Diagnostics|April 6, 2011
miRNA control of apoptotic programs: focus on ovarian cancerDelia Mezzanzanica, Silvana Canevari, Loris De Cecco, et al.
Cancers|April 3, 2021
Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent DatasetsLoris De Cecco, Marina Bagnoli, Paolo Chiodini, et al.
The International Journal of Biochemistry & Cell Biology|December 29, 2009
Role of microRNAs in ovarian cancer pathogenesis and potential clinical implicationsDelia Mezzanzanica, Marina Bagnoli, Loris De Cecco, et al.
Current Treatment Options in Oncology|May 6, 2017
Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?Luca Tonella, Marco Giannoccaro, Salvatore Alfieri, et al.
Critical Reviews in Oncogenesis|April 26, 2013
Measuring microRNA expression levels in oncology: from samples to data analysisLoris De Cecco, Matteo Dugo, Silvana Canevari, et al.
International Journal of Oncology|September 25, 2008
Clusterin: a potential target for improving response to antiestrogensSara Toffanin, Maria Grazia Daidone, Patrizia Miodini, et al.
Clinical Therapeutics|October 22, 2019
Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck CancerCarla Rognoni, Silvana Quaglini, Jan Baptist Vermorken, et al.
The Journal of Molecular Diagnostics : JMD|December 25, 2012
MicroRNA detection in plasma samples: how to treat heparinized plasmaPaola Tiberio, Loris De Cecco, Maurizio Callari, et al.
Genes|September 8, 2019
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot StudyMatteo Dugo, Andrea Devecchi, Loris De Cecco, et al.
Pageof 18